Efficacy and safety of low-dose vs medium-dose bevacizumab for radiation-induced brain necrosis in nasopharyngeal carcinoma survivors
Our results showed that there was no significant difference of the efficiency between the low-dose bevacizumab and conventional medium-dose bevacizumab for RN patients after NPC. In addition, the adverse events were less common in low-dose group.
Authors
- Yong He (ORCID: https://orcid.org/0000-0002-7039-2850)
- Yongteng Xu (ORCID: https://orcid.org/0000-0001-8989-9048)
- Yi Li (ORCID: https://orcid.org/0000-0002-4965-297X)
- Dong Pan (ORCID: https://orcid.org/0000-0002-5952-5683)
- Bin Qi (ORCID: https://orcid.org/0000-0003-4176-5758)
- Honghong Li (ORCID: https://orcid.org/0000-0003-4141-5045)
- Yamei Tang (ORCID: https://orcid.org/0000-0002-6353-6107)
Institutions
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Neurological Research
- Published
- 2025-07-05
- DOI
- https://doi.org/10.1080/01616412.2025.2528155
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Guangzhou Science and Technology Program key projects